Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.25M$2.25Mderived−16.4% vs Q4 2014 Net Income-$6.59M-$6.59MderivedN/M vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,406,180+10.3% Operating Incomederived-$5,625,992N/M Operating Cash Flowderived-$1,284,090N/M Free Cash Flowderived-$1,307,633N/M Margins · derivedGross margin62.5%+15.2 pt vs Q4 2014
Operating margin-250.0%+74.2 pt vs Q4 2014
Net margin-292.9%+32.1 pt vs Q4 2014
ended Dec 31, 2015 · filed Apr 14, 2016 · 105 d after period end